Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1278, 2009-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
FDA launches initiative for safe use of inhalation drugs in kids
Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. :
US FDA alerts public to safe use of transdermal fentanyl patches
Reactions Weekly, Vol. 1, Iss. 1061, 2005-01 ,pp. :
Ty Pennington announces launch of lisdexamfetamine for adult ADHD in US.
Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. :
US FDA announces ongoing assessment of CV risk for Stalevo
Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. :
US FDA announces new rule to help stem antibacterial resistance . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. :